Scientist (3rd party), Biomarker Research
職位描述
職位描述:
DESCRIPTION
The successful candidate will join a multidisciplinary research team focusing on drug discovery, translational research, and early development of novel small or large molecule drug candidates in Shanghai, China. This person is expected to take responsibilities in immunohistochemistry (IHC) assay development and execution, to provide histo-pathology support to biomarker research and joint projects with drug discovery, translational research, and early development teams. The successful candidate should have a well-established track record in Bio-medical research, ideally working experience in pathology platform of pharmaceutical R&D or CRO. Good communication skills in both English and Chinese, as well as an ability to interact with collaboration partners both internally and externally.
TECHNICAL SKILLS, EXPERIENCE & KNOWLEDGE:
A thorough understanding of immunohistochemistry and histo-pathology
An ability to independently generate precise, reliable data and skillfully analyze and interpret it
Hands-on experience in preparation, fixation, embedding, sectioning of FFPE samples, and IHC assay execution, data capture is a must
Hands-on experience in developing, validating and executing common oncology/immunology biomarker IHC assays independently is an advantage
Experience with pathological quantitation and scoring is a strong plus
Experience with fluorescent staining, FISH, ViewRNA on clinical samples is a strong plus
KEY RESPONSIBILITIES
Routine characterization of cellular, pre-clinical, clinical samples with established biomarker assays, eg. IHC, WB etc.
Develop, optimize, validate, trouble shoot and execute IHC and other histo-pathology assays
Integrate appropriate automated devices to improve assay throughput and robustness
The successful candidate is expected to analyze, interpret and report experimental results independently
The successful candidate may be actively engaged in participating and evaluating progress in collaborative programs with external partners. Experience in collaborative research would be desirable
EDUCATION, EXPERIENCE, QUALIFICATIONS
The candidate should have a Master/PhD/MD degree in medicine, biology, pathology or a related field, preferably experience in pre-clinical drug discovery or translational research in a pharmaceutical setting or other relevant healthcare industry.
A thorough understanding and experience in cancer biology is a plus.
Hands on experience with cutting edge cellular and molecular technologies related to Oncology biomarker research would be a clear advantage.
Demonstrated ability to work in a team oriented environment.
Good written and oral communication skill in both English and Chinese
企業簡介
美國強生公司創建于1886年,目前在全球60個國家建立了250多家分公司,是目前世界上最具綜合性、業務分布范圍最廣的衛生保健產品的制造商和相關服務提供商,業務領域主要包括制藥,醫療器械和消費品。
西安楊森制藥有限公司是美國強生公司在華最大的子公司,成立于1985年。公司管理中心在北京,生產基地位于西安,在全國28個城市設有辦事處,在華員工超過3000人。在過去的25年中,西安楊森保持持續穩定發展,成為了中國領先的合資制藥企業。
西安楊森不斷引進和生產多種創新的、高品質的藥品,其產品包括多種高質量的處方藥,以及廣受患者信賴的非處方藥物。西安楊森依托強生公司全球強大的研究開發體系,著眼于未來,不斷引進新的藥品,計劃上市生物制劑、腫瘤、心血管、風濕和泌尿等更多領域的產品以服務于中國的廣大患者。
西安楊森公司遵從強生信條的原則,致力于公司的長期發展。這是公司在過去取得成功的基石,也是未來成長的保障。
西安楊森公司獲得眾多獎項和贊譽,比如《財富》雜志評選的“中國最受贊賞的外資企業”及“人力資源經理眼中的熱門雇主”;中國中央電視臺 “2005CCTV中國年度雇主”;CRF評選的2007-2008年度北京地區“中國杰出雇主”;2008年與強生在華公司一起榮獲“第六屆中國大學生最佳雇主獎和進步飛速獎”稱號,和2009年“第七屆中國大學生最佳雇主獎”,并位列醫藥行業第一名。2010年強生在華公司榮獲“第八屆中國大學生最佳雇主制藥/醫療行業最佳雇主第一名”。這是繼上屆強生公司獲得醫藥行業第一名后再次蟬聯這項榮譽。
熱門區域招聘: 重慶 北京 上海 浙江 江蘇 廣東 山東 湖南 安徽 河北
上海招聘企業: 百進冠合(海南) 醫療科技有限公司 上海華茂藥業有限公司 上海信誼藥廠有限公司 上海強生制藥 歐姆龍健康醫療(中國)有限公司 青海瑞成藥業(集團)有限公司 上海交通大學醫學院附屬瑞金醫院 復旦大學附屬中山醫院 上海復星醫藥 上海醫藥集團
職位發布日期: 2016-11-23